Institutional report - Congenital development of novel drug-eluting biodegradable nano-fiber for prevention of postoperative pulmonary venous obstruction

Interactive Cardiovascular and Thoracic Surgery

Volumn 8, Issue 4, 2009, Pages 402-406

  Mutsuga, Masato ^a   Narita, Yuji ^a,b   Yamawaki, Aika ^b   Satake, Makoto ^c   Kaneko, Hiroaki ^c   Usui, Akihiko ^a   Ueda, Yuichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TEIJIN LTD   (Japan)

Author keywords

Intimal hyperplasia; Nano fiber; Pulmonary venous obstruction; Tacrolimus; Total anomalous pulmonary venous connection

Indexed keywords

NANOFIBER; POLYGLACTIN; TACROLIMUS; CARDIOVASCULAR AGENT; NANOMATERIAL; PACLITAXEL; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFECTION; LUNG VEIN OBSTRUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SUSTAINED DRUG RELEASE; ANASTOMOSIS; ANIMAL; ARTICLE; BIODEGRADABLE IMPLANT; CELL PROLIFERATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYPERPLASIA; INFERIOR CAVA VEIN; INTIMA; MATERIALS TESTING; PATHOLOGY; PROSTHESIS; PULMONARY VENO-OCCLUSIVE DISEASE; TIME; VASCULAR SMOOTH MUSCLE; WISTAR RAT; MEDICAL RESEARCH; THROMBOSIS;

ABSORBABLE IMPLANTS; ANASTOMOSIS, SURGICAL; ANIMALS; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-ELUTING STENTS; HUMANS; HYPERPLASIA; MALE; MATERIALS TESTING; MUSCLE, SMOOTH, VASCULAR; NANOSTRUCTURES; POLYGLACTIN 910; PROSTHESIS DESIGN; PULMONARY VENO-OCCLUSIVE DISEASE; RATS; RATS, WISTAR; TACROLIMUS; TIME FACTORS; TUNICA INTIMA; VENA CAVA, INFERIOR;

EID: 65249109270     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.192831     Document Type: Conference Paper

References (13)

1. Caldarone CA, Najm HK, Kadletz M, Smallhorn JF, Freedom RM, Williams WG, Coles JG. Surgical management of total anomalous pulmonary venous drainage: impact of coexisting anomalies. Ann Thorac Surg 1998;66:1521-1526.
2. Devaney EJ, Chang AC, Ohye RG, Bove EL. Maagement of congenital and acquired pulmonary vein stenosis. Ann Thorac Surg 2006;81:992- 996.
3. Lacour-Gayet F, Zoghbi J, Serraf AE, Belli E, Pilot D, Rey C, Marcon F, Bruniaux J, Planche C. Surgical management of progressive pulmonary venous obstruction after repair of total anomalous pulmonary venous connection. J Thorac Cardiovasc Surg 1999;117:679-687.
4. Ricci M, Elliot M, Cohen GA, Catalan G, Stark J, de Leval MR, Tsang VT. Management of pulmonary venous obstruction after correction of TAPVC: risk factors for adverse outcome. Eur J Cardiothorac Surg 2003; 24:28-36.
5. Caldarone CA, Najm HK, Kadletz M, Smallhorn JF, Freedom RM, Williams WG, Coles JG. Surgical management of total anomalous pulmonary venous drainage: impact of coexisting anomalies. Ann Thorac Surg 1998;66:1514-1520.
6. Lacour-Gayet F, Rey C, Planche C. Pulmonary vein stenosis. Description of a sutureless surgical procedure using the pericardium in situ. Arch Mal Coeur Vaiss 1996;89:633-636.
7. Mutsuga M, Narita Y, Yamawaki A, Satake M, Kaneko H, Suematsu Y, Usui A, Ueda Y. A new strategy for prevention of anastomotic stricture using tacrolimus eluting biodegradable nanofiber. J Thorac Cardiovasc Surg in press.
8. Bartorelli AL, Trabattoni D, Fabbiocchi F, Montorsi P, de Martini S, Calligaris G, Teruzzi G, Galli S, Ravagnani P. Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent. J Interv Cardiol 2003;16:499-505.
9. Wallemacq PE, Reding R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clinical Chemistry 1993;39:2219-2228.
10. Herlong JR, Jaggers JJ, Ungerleider RM. Congenital heart surgery nomenclature and database project: pulmonary venous anomalies. Ann Thorac Surg 2000;69:56-69.
11. Van Son JAM, Danielson GK, Puga FJ, Edwards WD, Dricolli DJ. Repair of congenital and acquired pulmonary vein stenosis. Ann Thorac Surg 1995;60:144-150.
12. Haworth SG, Reid L. Structural study of pulmonary circulation and of heart in total anomalous pulmonary venous return in early infancy. Br Heart J 1977;39:80-92.
13. Sands A, Craig B, Casey F. A possible role for steroid therapy in preventing postoperative stenosis in TAPVC. Cardiol Young 1998;8:240- 242.